Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 1999

Long term results of interferon alpha treatment in children with chronic hepatitis B

Dariusz M. Lebensztejn, Maciej Kaczmarski, Maria E. Sobaniec-Łotowska

Med Sci Monit 1999; 5(6): CR1129-1133 :: ID: 503159

Abstract

The aim of the study was a long-term evaluation of therapeutic efficiency of interferon alpha (IFN alpha) in children with diagnosed chronic hepatitis B (ch B). 79 children with the clinical and histopathological diagnosis of chronic hepatitis were subject to observation. The treatment with IFN alpha was applied to 55 children with HBs and HBe antigens persisting for over 6 months. Control group was formed of 24 children who did not receive IFN alpha. 12 months after the completion of treatment with IFN, the absence of HBV DNA polymerase in blood serum was recorded in 66% patients, 53% displayed HBeAg/antiHBeAg seroconversion and 7% patients manifested HBsAg/antiHBs seroconversion. HBeAg/antiHBe seroconversion occurred in 25% children from control group. 24 months after the end of treatment course, the absence of HBe antigen was recorded in 65% patients and the absence of HBs antigen - in 11% patients. 36 months after therapy completion, these values increased to 77% and 19% children receiving IFN alpha, respectively. The recurrence of HBV antigens was not observed in any of the analysed children.

Keywords: interferon alpha, children, HBV infection, chronic hepatitis

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750